Study of Survivors of Different Types of Cardiac Arrest and Their Neurological Recovery

NCT02033720 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2014-01-13

No results posted yet for this study

Summary

After successful resuscitation from certain types of cardiac arrest, total body cooling is now a well established treatment that improves the chances of the brain recovering. This however, has only been definitively proven after a certain type of cardiac arrest that is "ventricular fibrillation / ventricular tachycardia". The purpose of this study is to explore if total body cooling is beneficial for patients recovering from another type of cardiac arrest that is "pulseless electrical activity".

HYPOTHESIS:

Patients undergoing post-cardiac arrest therapeutic hypothermia have better neurological outcomes if their initial arrest rhythm is pulseless electrical activity (PEA) in comparison to asystole.

Conditions

  • Postcardiac Arrest
  • Pulseless Electrical Activity
  • Asystole

Interventions

OTHER

No treatment

No therapeutic hypothermia was induced.

OTHER

Therapeutic hypothermia

Hypothermia was induced after successful resuscitation from cardiac arrest.

Sponsors & Collaborators

  • University of Western Ontario, Canada

    collaborator OTHER
  • London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

    lead OTHER

Principal Investigators

  • Eyad Althenayan, MD · Western University, Canada

  • Philip Jones, MD, FRCPC · Western University, Canada

  • Bryan Young, MD, FRCPC · Western University, Canada

  • Ahmed F Hegazy, MD, FRCPC · Western University, Canada

  • Ana Igric, MD, FRCSC · Western University, Canada

  • Carolyn Benson, MD · Western University, Canada

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2014-12-31
Completion
2015-02-28

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02033720 on ClinicalTrials.gov